ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 760016 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 760016; 2) Community: the network communities that were significantly associated with the response to NSC 760016; 3) Molecule: the relationships between components within communities and NSC 760016; 4) MDR: the compounds that were significantly associated with the NSC 760016.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0348927754043159 0.34711332
NSC 30915 Null 0.0348927754043159 0.25773184
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0348927754043159 0.14988503
NSC 339137 PHYSALOLACTONE 0.0348927754043159 0.29088394
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0348927754043159 0.3456568
NSC 34757 Melicopidine 0.0348927754043159 0.31483315
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0348927754043159 0.316797
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0348927754043159 0.29489978
NSC 359239 Antibiotic X-14766A 0.0348927754043159 0.010385564
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0348927754043159 0.26039652
Total:205  Current:162    [First] [Prev] [Next] [Last]